Log in for full access to this activity, if you are registered.

Registration Options

Activity Dates: 06/12/2014 - 04/28/2017

This course is closed. Please look for other available products in CPNP University.

Target Audience

This course is designed for pharmacists, nurse practitioners or other healthcare professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

The Food and Drug Administration continues to classify marijuana as a Schedule I substance, implying that it has a high potential for abuse without a currently accepted medical use. However, twenty states and the District of Columbia permit the medical use of marijuana. Colorado has both the highest per-capita use of medical marijuana and one of the most regulated medical marijuana systems.

In this debate session, we welcome two investigators from Colorado to debate medical marijuana. The presenters will first consider if marijuana should remain a Schedule I substance or be rescheduled to allow investigators to better study its risks and benefits as a Schedule II substance. Second, the presenters will discuss if physicians should prescribe medical marijuana in a similar manner to other prescription medications, weighing the potential benefits and risks of a medication, as well as what it means for a physician to recommend marijuana compared with prescribing marijuana. Next, the presenters will discuss pharmacists dispensing medical marijuana dispensing, including recent examples of laws enabling this role. Lastly, the presenters will speculate on the future use of marijuana as a medicine.

Upon conclusion of the program, the participant should be able to describe the historical and current legal status of marijuana, evaluate the medical benefits and risks associated with medical marijuana, identify known psychiatric consequences and drug interactions with marijuana use, discuss the role of pharmacists when patients choose to use medical marijuana, and predict the future of medical marijuana in the United States.

 

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (login first)
  • Complete the evaluation at the end of the activity. (login first)
  • If necessary, complete the post-test retest no later than the closing activity date. (login first)
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)

This course is provided online at cpnp.org and consists of the speaker audio and slides. A PDF file of the slides is also provided and access is available to participants indefinitely although ACPE credit is available only through the course expiration date.

Participants in this course must complete an examination and achieve a score of 70% or greater. Successful completion of the course also requires the completion of a course evaluation. ACPE statements of credit can be retrieved by participants online at cpnp.org immediately upon successful completion of the course.

Faculty Information and Disclosures

Laura Borgelt, PharmD, FCCP, BCPS
Abraham Nussbaum, MD, MTS

View biographical information and disclosures

Learning Objectives

  1. Describe the historical and current legal status of marijuana.
  2. Evaluate the medical benefits and risks associated with medical marijuana.
  3. Identify known psychiatric consequences and drug interactions with marijuana use.
  4. Discuss the role of pharmacists when patients choose to use medical marijuana.
  5. Predict the future of medical marijuana in the United States.

Continuing Education Credit and Disclosures

Activity Dates: 06/12/2014 - 04/28/2017
ACPE Contact Hours: 2.0
ACPE Number: 0284-0000-14-008-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This course provides 2.0 contact hours (0.20 CEUs) of knowledge-based continuing education credit. The ACPE universal program number assigned to this course is 0284-0000-14-008-H01-P (2.0 contact hours).